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cell reconstitution and induces tolerance to bone marrow
grafts even in the absence of conditioning providing a new
tool for clinical translation especially in childrenwith SCID or
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Background: Hematopoietic cell transplantation (HCT) is a
resource-intensive therapy. The economic costs to the
medical system have been well-described; however,
few studies have prospectively assessed the ﬁnancial
consequences of HCT for patients and their families.
Methods: We report preliminary data from a prospective
study of ﬁnancial hardship related to HCT. We mailed a
41-item questionnaire to adult patients approximately six
months post-allogeneic or autologous HCT at three sites
(Dana-Farber Cancer Institute [DFCI], Roswell Park Cancer
Institute, and Mayo Clinic Arizona). The questionnaire was
developed with input from a focus group of HCT nurses and
social workers, and underwent formal cognitive debrieﬁng
with HCT patients. HCT-related clinical outcomes associated
with hardship will be assessed at one year. We present the
ﬁnancial experience of the ﬁrst cohort of DFCI patients.
Results: As of October 1, 2014, of 174 surveys mailed, 124 had
been received (71%). Patients were a median of 174 days
post-HCT. The mean age was 57.6 years, 49% had had an
allogeneic transplant, 95% were white, 75% were married,
24% had at least one child at home, 52% were currently
working at least part-time or taking a leave of absence, and
46% had at least a bachelor’s degree. Patients came from 10
states; the top three were MA (45%), ME (14%) and NY (13%).
Compared to before transplant, 48% reported a decline in
monthly household income. Nearly half (48%) were also only
somewhat, slightly or not at all satisﬁed with their present
ﬁnancial situation, and 41% reported somewhat, moderate or
extreme difﬁculty in making bill payments. About one out of
ﬁve (21%) reported substantial hardship, deﬁned as not
having enough money at the end of the month, and 52.4%
(95% CI [43.5, 61.3]) reported either unsatisfactory income,
difﬁculty making payments, or substantial hardship.
Transplant type, gender, age, race, employment and college
degree were not signiﬁcantly associated with substantial
hardship; however, being unmarried (p< .03) and lower
income level (p<.02) were. Patients reported several
ﬁnancial coping strategies post-HCT (see table), which
differed among those with substantial hardship.Reduced spending
on essential items
Withdrew
from savings
Percent of all respondents 47% 43%
Odds ratio for substantial
hardship vs. other [95% CI]
6.4 [ 2.2, 18.7] 3.5 [ 1.4, 8.9]Conclusions: The majority of HCT patients face ﬁnancial
difﬁculties, particularly those who are not married or have
more limited income. Coping strategies vary, although
spending on prescription medicines is largely preserved.
Several strategies are much more prevalent among those
with substantial hardship. The ultimate effects of ﬁnancial
burden on HCT outcomes remain to be demonstrated.59
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Background: Approximately 10% of older (65y) individuals
in the general population demonstrate frailty (Collard RM et
al. J Am Geriatr Soc. 2012;60:1487-92). HCT recipients are at
risk for accelerated aging, given the high-intensity
therapeutic exposures and excessive burden of morbidity
after HCT. We examined the prevalence and predictors of
frailty in elderly (65y) HCT survivors.
Methods: Participants included 276 older HCT survivors
(median age at study participation: 70 y (65-84), who had
undergone HCT (allogeneic: n¼83, autologous: n¼196)
between 1985-2010. Median time from HCT was 8.9y
(3.7-29.1). Following well established survey-based screening
tools for frailty (Pialoux T et al. Geriatr Gerontol Int.
2012;12:189-97), all participants completed a self-report
survey that included questions pertaining to: low leanmuscle
mass, self-reported exhaustion, low energy expenditure, slow
walking speed, and muscle weakness. Prefrailty included 2,
while frailty included 3 conditions.
Results: The prevalence of prefrailty and frailty was 28% and
13%, respectively.Predictors of pre-frailty and/or frailty
After adjusting for age at enrollment, sex, race, education
and employment status, survivors with low income (annual
household income <$50,000/annual personal income
<$20,000) were 3.2 times more likely to report pre-frailty
and/or frailty (OR¼3.2, 1.5-6.9, p¼0.003); furthermore,
allogeneic HCT survivors with a history of cGvHD were 2.7
times more likely to report pre-frailty and/or frailty (OR¼2.7,
1.2-6.3, p¼0.02) than autologous HCT survivors.Borrowed money
to pay bills
Reduced leisure
activities
Cut back on prescribed
medicine
24% 59% 5%
7.9 [ 3.0, 20.7] 7.2 [2.0, 25.6] 8.4 [1.4, 48.6]
